Substandard/counterfeit antimicrobial drugs are a growing global problem. The most
common substandard/counterfeit antimicrobials include beta-lactams (among antibiotics) …

Poor‐quality medicines present a serious public health problem, particularly in emerging
economies and developing countries, and may have a significant impact on the national …

There is growing universal concern regarding counterfeit medications. In particular,
counterfeit antimicrobial drugs are a threat to public health with many devastating …

Background. We explored the association between antituberculosis drug pharmacokinetics
and treatment outcomes among patients with pulmonary tuberculosis in Botswana. Methods …

There is considerable exigency to take all necessary steps to cure tuberculosis cases and
prevent further emergence of drug-resistant tuberculosis. The most important of these steps …

Tuberculosis is a leading killer of young adults worldwide and the global scourge of multi-
drug resistant tuberculosis is reaching epidemic proportions. It is endemic in most …

The second edition of this practical authoritative reference book provides a rational basis for
the diagnosis and management of tuberculosis. Written by a number of experts in the field it …

This article describes the population pharmacokinetics of rifampin in South African
pulmonary tuberculosis patients. Three datasets containing 2,913 rifampin plasma …

Fixed-dose combination (FDC) formulations are currently recommended for the treatment of
active tuberculosis (TB). We have conducted a systematic review to evaluate the risk of …

The problem of poor/variable bioavailability of rifampicin, which is shown in particular when
the drugs are present in anti-tubercular fixed-dose combination (FDC) products, is a matter …